Literature DB >> 22514213

Population-level changes to promote cardiovascular health.

Torben Jørgensen1, Simon Capewell, Eva Prescott, Steven Allender, Susana Sans, Tomasz Zdrojewski, Dirk De Bacquer, Johan de Sutter, Oscar H Franco, Susanne Løgstrup, Massimo Volpe, Sofie Malyutina, Pedro Marques-Vidal, Zeljko Reiner, Grethe S Tell, W M Monique Verschuren, Diego Vanuzzo.   

Abstract

BACKGROUND: Cardiovascular diseases (CVD) cause 1.8 million premature (<75 years) death annually in Europe. The majority of these deaths are preventable with the most efficient and cost-effective approach being on the population level. The aim of this position paper is to assist authorities in selecting the most adequate management strategies to prevent CVD. DESIGN AND METHODS: Experts reviewed and summarized the published evidence on the major modifiable CVD risk factors: food, physical inactivity, smoking, and alcohol. Population-based preventive strategies focus on fiscal measures (e.g. taxation), national and regional policies (e.g. smoke-free legislation), and environmental changes (e.g. availability of alcohol).
RESULTS: Food is a complex area, but several strategies can be effective in increasing fruit and vegetables and lowering intake of salt, saturated fat, trans-fats, and free sugars. Tobacco and alcohol can be regulated mainly by fiscal measures and national policies, but local availability also plays a role. Changes in national policies and the built environment will integrate physical activity into daily life.
CONCLUSION: Societal changes and commercial influences have led to the present unhealthy environment, in which default option in life style increases CVD risk. A challenge for both central and local authorities is, therefore, to ensure healthier defaults. This position paper summarizes the evidence and recommends a number of structural strategies at international, national, and regional levels that in combination can substantially reduce CVD.

Entities:  

Keywords:  Cardiovascular; health promotion; population; prevention; public health; structural strategies

Mesh:

Year:  2012        PMID: 22514213     DOI: 10.1177/2047487312441726

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  22 in total

Review 1.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

2.  Cardiovascular prevention: the role of second generation of nutraceuticals.

Authors:  Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-21

Review 3.  [Cardiovascular prevention and regular physical exercise : Activity and training as the true "polypill"].

Authors:  H Löllgen; N Bachl
Journal:  Herz       Date:  2016-12       Impact factor: 1.443

Review 4.  Managing sedentary behavior to reduce the risk of diabetes and cardiovascular disease.

Authors:  Paddy C Dempsey; Neville Owen; Stuart J H Biddle; David W Dunstan
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

5.  Effectiveness and Feasibility of Taxing Salt and Foods High in Sodium: A Systematic Review of the Evidence.

Authors:  Rebecca Dodd; Joseph Alvin Santos; Monique Tan; Norm R C Campbell; Cliona Ni Mhurchu; Laura Cobb; Michael F Jacobson; Feng J He; Kathy Trieu; Sutayut Osornprasop; Jacqui Webster
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

6.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

7.  Neighbourhood socioeconomic status and coronary heart disease in individuals between 40 and 50 years.

Authors:  Axel C Carlsson; Xinjun Li; Martin J Holzmann; Per Wändell; Danijela Gasevic; Jan Sundquist; Kristina Sundquist
Journal:  Heart       Date:  2016-02-10       Impact factor: 5.994

8.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

9.  Reasons for (non)compliance with intervention following identification of 'high-risk' status in the NHS Health Check programme.

Authors:  R J McNaughton; J Shucksmith
Journal:  J Public Health (Oxf)       Date:  2014-09-18       Impact factor: 2.341

Review 10.  Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.

Authors:  Bin Zhou; Pablo Perel; George A Mensah; Majid Ezzati
Journal:  Nat Rev Cardiol       Date:  2021-05-28       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.